Advaxis, Inc.
20Patents
20Active
20Granted
53Portfolio score
Filing activity: May 10, 2007 → Oct 18, 2021 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9499602B2 | Non-hemolytic LLO fusion proteins and methods of utilizing same | Chemistry; Metallurgy | 26 | Active |
| US9017660B2 | Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors | Human Necessities | 21 | Active |
| US9084747B2 | Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors | Human Necessities | 16 | Active |
| US9549973B2 | Compositions and methods comprising KLK3 or FOLH1 antigen | Chemistry; Metallurgy | 16 | Active |
| US9463227B2 | Listeria-based adjuvants | Human Necessities | 16 | Active |
| US8956621B2 | Compositions and methods for treatment of cervical dysplasia | Chemistry; Metallurgy | 14 | Active |
| US9012141B2 | Compositions and methods comprising KLK3 of FOLH1 antigen | Chemistry; Metallurgy | 13 | Active |
| US9650639B2 | Dual delivery system for heterologous antigens | Human Necessities | 10 | Active |
| US9644212B2 | Dual delivery system for heterologous antigens | Human Necessities | 10 | Active |
| US9907849B2 | Combination of a PD-1 antagonist and a listeria-based vaccine for treating prostate cancer | Human Necessities | 7 | Active |
| US10064898B2 | Listeria-based adjuvants | Emerging Cross-Sectional Technologies | 7 | Active |
| US10258679B2 | Recombinant Listeria vaccine strains and methods of producing the same | Chemistry; Metallurgy | 6 | Active |
| US10143734B2 | Biomarker directed multi-target immunotherapy | Chemistry; Metallurgy | 6 | Active |
| US10058599B2 | Suppressor cell function inhibition following Listeria vaccine treatment | Emerging Cross-Sectional Technologies | 6 | Active |
| US10900044B2 | Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US11179339B2 | Compositions and methods for lyophilization of bacteria or listeria strains | Human Necessities | 4 | Active |
| US11446369B2 | Compositions and methods comprising KLK3 or FOLH1 antigen | Chemistry; Metallurgy | 3 | Active |
| US11702664B2 | Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US11897927B2 | Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US12239738B2 | Compositions and methods for lyophilization of bacteria or listeria strains | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.